BR Partners S.A. (BRBI) is an independent Brazilian investment bank headquartered in São Paulo and led by founder and CEO Ricardo Lacerda. The firm operates across four main business lines: investment banking, spanning mergers-and-acquisitions and restructuring advisory; capital markets, covering debt and equity issuance; treasury sales and structuring; and wealth management. The company's shares trade as units on Brazil's B3 exchange under the symbol BRBI11, while American depositary shares trade on Nasdaq under BRBI.
Investors follow BRBI for its exposure to Brazilian capital-markets activity and its high-return advisory franchise. The bank has historically posted strong return on equity and a generous dividend payout, and management has repeatedly highlighted a record pipeline of potential M&A mandates. At the same time, the business is cyclical, with revenue tied closely to deal closings, issuance volumes, and Brazil's interest-rate and political environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the past 30 days, BRBI shares have fallen approximately 50%, from roughly $15.30 to around $7.60. The decline was abrupt rather than gradual: the stock traded near $15 in the third week of October before collapsing within days. Much of the damage came in a single session in late October, when the shares fell by roughly a third after a capital-markets announcement, with selling continuing into early November.
The three-month picture is more complex. BRBI began the quarter near $9, rallied sharply through September and October to a peak above $15, and then gave back nearly all of those gains. Measured from mid-August to mid-November, the stock is down about 16% — but that headline figure obscures a rise of roughly 65–70% followed by a decline of about 50% from the peak.
The primary catalyst for the sharpest leg lower was the announcement in late October that BR Partners Banco de Investimento, a wholly owned subsidiary, had issued R$124.2 million in perpetual subordinated notes in a private placement with institutional investors. Because the notes are perpetual and include repurchase options every five years, market participants interpreted the size and structure of the issuance as a potential source of dilution and as a signal of near-term capital or liquidity stress, triggering heavy selling.
That move was amplified by a broader repricing of Brazilian financial assets following the presidential election, which produced the sharpest post-election weekly decline in Brazilian equities in decades. With interest rates expected to remain elevated, investors demanded higher risk premiums across capital-markets-sensitive names. Against this backdrop, several research firms turned more cautious: Citi downgraded BRBI to Neutral from Buy and cut its price target, while Itaú BBA moved the stock to a market-perform rating and lowered its own target. Third-quarter results, which showed net income down about 44% year over year on softer investment-banking and client revenues plus higher credit provisions, added to the negative sentiment.
The broader three-month trend reflects a tug-of-war between an improving deal pipeline and a difficult macro backdrop. Through September and October, the shares rallied as investors anticipated a stronger fourth quarter and a rebound in Brazilian capital-markets activity, and as the Nasdaq-listed ADRs continued to broaden the company's international investor base. However, weaker second- and third-quarter results, postponed investment-banking closings, a rising expense base, and election-driven volatility eventually overwhelmed the positive narrative.
The reversal accelerated once the perpetual-notes issuance raised questions about capital structure and once analysts repriced the stock for a "higher-for-longer" interest-rate environment. Management has argued the market reaction was excessive, citing a record M&A pipeline, but has acknowledged that converting that pipeline into recognized revenue depends on a more favorable rate and economic outlook.
Investors will likely focus on whether BR Partners can convert its record M&A pipeline into closed transactions and recognized revenue, and whether capital-markets and debt-issuance volumes stabilize after a weaker third quarter. Earnings releases and management guidance on fees, credit provisions, and expense discipline will be closely watched, as will any further balance-sheet or capital-raising actions and how the market assesses the company's leverage.
At the macro level, Brazil's interest-rate trajectory, fiscal policy under the new administration, and the implementation of tax reform remain key swing factors for capital-markets activity. Analyst estimate revisions and price-target changes, along with the pace of foreign-investor participation in the ADRs, could also influence sentiment. These factors carry meaningful uncertainty, and outcomes may differ materially from current expectations. From what I see, monitoring these elements closely will be essential in the coming months.
In my research process, I often turn to Tickeron’s AI Trend Prediction Engine to get additional perspective on momentum and pattern signals for financial stocks like BRBI. This helps cross-check traditional analysis with data-driven insights before forming a final view on near-term drivers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The RSI Oscillator for BRBI moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 4 similar instances when the indicator left oversold territory. In 4 of the 4 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 13 of 15 cases where BRBI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
Following a +6.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBI advanced for three days, in 45 of 56 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BRBI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRBI as a result. In 17 of 23 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for BRBI turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In 8 of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
BRBI moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BRBI crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for BRBI entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.235) is normal, around the industry mean (3.120). P/E Ratio (3.554) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.077) settles around the average of (8.976) among similar stocks. P/S Ratio (0.121) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. BRBI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers